ArticleJournal of clinical pharmacology2024

A Model-Based Approach Supporting Abacavir/Dolutegravir/Lamivudine Fixed-Dose Combination Approval in Children Living with HIV-1.

Hardik Chandasana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.